Details for New Drug Application (NDA): 089517
✉ Email this page to a colleague
NDA 089517 describes POLOCAINE W/ LEVONORDEFRIN, which is a drug marketed by Dentsply Pharm and is included in one NDA. Additional details are available on the POLOCAINE W/ LEVONORDEFRIN profile page.
The generic ingredient in POLOCAINE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
The generic ingredient in POLOCAINE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 089517
| Tradename: | POLOCAINE W/ LEVONORDEFRIN |
| Applicant: | Dentsply Pharm |
| Ingredient: | levonordefrin; mepivacaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.05MG/ML;2% | ||||
| Approval Date: | Apr 14, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
